These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2984636)

  • 1. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine.
    Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
    Pediatrics; 1985 Apr; 75(4):667-71. PubMed ID: 2984636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varicella in the neonatal ICU due to the Varicella vaccine Oka strain.
    Frantzis I; Messina M; Taylor JM; Aschheim K; Hu H; Hairston JC; Lauren CT; Gershon A; Feldstein N; Orange J; Saiman L
    J Neonatal Perinatal Med; 2023; 16(1):179-182. PubMed ID: 36744349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal varicella antibodies in children aged less than one year: Assessment of antibody decay.
    Bolotin S; Hughes SL; Savage RD; McLachlan E; Severini A; Arnold C; Richardson S; Crowcroft NS; Deek S; Halperin SA; Brown KA; Hatchette T; Osman S; Gubbay JB; Science M
    PLoS One; 2023; 18(11):e0287765. PubMed ID: 37948389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing vaccination policies based upon scientific evidence in Japan.
    Yoshikawa T
    Vaccine; 2021 Sep; 39(38):5447-5450. PubMed ID: 34373119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices (ACVIP): Recommended Immunization Schedule (2020-21) and Update on Immunization for Children Aged 0 Through 18 Years.
    Kasi SG; Shivananda S; Marathe S; Chatterjee K; Agarwalla S; Dhir SK; Verma S; Shah AK; Srirampur S; Kalyani S; Pemde HK; Balasubramanian S; Parekh BJ; Basavaraja GV; Gupta P
    Indian Pediatr; 2021 Jan; 58(1):44-53. PubMed ID: 33257602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infectious diseases and vaccination strategies: how to protect the "unprotectable"?
    Bozzola E; Bozzola M; Calcaterra V; Barberi S; Villani A
    ISRN Prev Med; 2013; 2013():765354. PubMed ID: 24977097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults.
    Macartney K; Heywood A; McIntyre P
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD001833. PubMed ID: 24954057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell immunity to human alphaherpesviruses.
    Ouwendijk WJ; Laing KJ; Verjans GM; Koelle DM
    Curr Opin Virol; 2013 Aug; 3(4):452-60. PubMed ID: 23664660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries.
    Poletti P; Melegaro A; Ajelli M; Del Fava E; Guzzetta G; Faustini L; Scalia Tomba G; Lopalco P; Rizzo C; Merler S; Manfredi P
    PLoS One; 2013; 8(4):e60732. PubMed ID: 23613740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes zoster vaccine for the elderly: boosting immunity.
    Chua JV; Chen WH
    Aging health; 2010 Apr; 6(2):169-176. PubMed ID: 20607105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of varicella vaccine on varicella-zoster virus dynamics.
    Schmid DS; Jumaan AO
    Clin Microbiol Rev; 2010 Jan; 23(1):202-17. PubMed ID: 20065330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary vaccine failure after 1 dose of varicella vaccine in healthy children.
    Michalik DE; Steinberg SP; Larussa PS; Edwards KM; Wright PF; Arvin AM; Gans HA; Gershon AA
    J Infect Dis; 2008 Apr; 197(7):944-9. PubMed ID: 18419532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination against Herpes Zoster and Postherpetic Neuralgia.
    Oxman MN; Levin MJ;
    J Infect Dis; 2008 Mar; 197 Suppl 2(Suppl 2):S228-36. PubMed ID: 18419402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-year follow-up of protection rates in children given varicella vaccine.
    Scheifele DW; Halperin SA; Diaz-Mitoma F
    Can J Infect Dis; 2002 Nov; 13(6):382-6. PubMed ID: 18159415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines.
    Huang DB; Wu JJ; Tyring SK
    J Infect; 2004 Oct; 49(3):179-209. PubMed ID: 15337336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella control and vaccine coverage: issues and challenges.
    Wallington T; Weir E
    CMAJ; 2002 Mar; 166(5):631-2. PubMed ID: 11898945
    [No Abstract]   [Full Text] [Related]  

  • 17. Active immunization in the United States: developments over the past decade.
    Dennehy PH
    Clin Microbiol Rev; 2001 Oct; 14(4):872-908, table of contents. PubMed ID: 11585789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varicella vaccination--a critical review of the evidence.
    Skull SA; Wang EE
    Arch Dis Child; 2001 Aug; 85(2):83-90. PubMed ID: 11466178
    [No Abstract]   [Full Text] [Related]  

  • 19. 25 years' experience with the Biken Oka strain varicella vaccine: a clinical overview.
    Takahashi M
    Paediatr Drugs; 2001; 3(4):285-92. PubMed ID: 11354700
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.